A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML
Clinical trial NCT05690425 · UNKNOWN
Trial details
- NCT number
- NCT05690425
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2024-03-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.